Frontiers | Identifying prodromal symptoms at high specificity for Parkinson’s disease
Introduction: To test drugs with the potential to prevent the onset of Parkinson’s disease (PD), it is key to identify individuals in the general population at high risk of developing PD. This is often difficult because most of the clinical markers are non-specific, common in PD but also common in older adults (e.g., sleep problems). Objective: We aimed to identify the clinical markers at high specificity for developing PD by comparing individuals with PD or prodromal PD to healthy controls. Methods: We investigated motor and non-motor symptoms (Movement Disorder Society Unified Parkinson’s Disease Rating Scale Part 1 and 2 items) in 64 prodromal PD and 422 PD individuals calculating the odds ratios, adjusting for age and gender, for PD and prodromal PD versus 195 healthy controls. Symptoms at high specificity were defined as having an adjusted odds ratio ≥ 6. Results: Constipation had an adjusted odds ratio, 6.14 [95% CI: 2.94–12.80] showing high specificity for prodromal PD, and spee
;import{g as i,s as o,r as s,e as a,a as u,h as l,b as c,i as h,t as f,c as d,d as p,f as m,j as g,k as y,l as b,K as v,_ as w,S as E,m as _,o as C,w as M,n as S,p as O,q as B,u as D,v as I,x as T,y as x,z as R,A as N,U as k,H as F,B as L,C as P,Y as U,D as j,E as q,F as z,G as $,I as V,J as H,L as W,M as G,N as K,O as Z,P as Y,Q as J,R as X,T as Q,V as AA,W as eA,X as tA,Z as rA,$ as nA,a0 as iA,a1 as oA,a2 as sA,a3 as aA,a4 as uA,a5 as lA,a6 as cA,a7 as hA,a8 as fA,a9 as dA,aa as pA,ab as mA,ac as gA,ad as yA,ae as bA,af as vA,ag as wA,ah as EA,ai as _A,aj as CA,ak as MA,al as SA,am as OA,an
Explore this link on the map →related reading
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- Frontiers | Why Harmless Sensations Might Hurt in Individuals with Chronic Pain: About Heightened Prediction and Perception of Pain in the Mindfrontiersin.org
- Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- The Parkinson’s Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Coho...protocols.io
- Frontiers | A Bayesian model for chronic painfrontiersin.org
- Checking your browser - reCAPTCHAncbi.nlm.nih.gov
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- Frontiers | Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportfrontiersin.org
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study - PMCpmc.ncbi.nlm.nih.gov
- Checking your browser - reCAPTCHApmc.ncbi.nlm.nih.gov
- Frontiers | Principles and Practice of Explainable Machine Learningfrontiersin.org